Ranbaxy Stability Testing System Draws FDA GMP Warning Letter
An FDA analysis of isotretinoin samples following a February inspection finds “lower potencies in these batches” before their expiration dates.
An FDA analysis of isotretinoin samples following a February inspection finds “lower potencies in these batches” before their expiration dates.